Incidence and characteristics of uterine leiomyomas with FDG uptake

Annals of Nuclear Medicine

Volumn 22, Issue 9, 2008, Pages 803-810

  Nishizawa, Sadahiko ^a   Inubushi, Masayuki ^a   Kido, Aki ^a   Miyagawa, Masao ^a   Inoue, Takeshi ^a   Shinohara, Katsura ^a   Kajihara, Makoto ^a  

^a Hamamatsu Medical Imaging Center   (Japan)

Author keywords

FDG PET; Genitourinary oncology; MRI; Uterine leiomyomas

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DRUG UPTAKE; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; SIGNAL DETECTION; UTERUS MYOMA; WHOLE BODY CT;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INCIDENCE; JAPAN; LEIOMYOMA; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; RADIOPHARMACEUTICALS; RISK ASSESSMENT; RISK FACTORS; UTERINE NEOPLASMS;

EID: 57049140587     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-008-0184-6     Document Type: Article

References (29)

1. G.J. Cook I. Fogelman M.N. Maisey 1996 Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation Semin Nucl Med 26 308 314
2. B.A. Gordon F.L. Flanagan F. Dehdashti 1997 Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations AJR 169 1675 1680
3. P.D. Shreve Y. Anzai R.L. Wahl 1999 Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants Radiographics 19 61 77
4. 18F-FDG endometrial and ovarian uptake in pre-and post-menopausal patients: assessment by PET/CT J Nucl Med 45 266 271
5. 18F-FDG uptake in the ovaries and uterus of healthy female volunteers Eur J Nucl Med Mol Imaging 32 549 556
6. S. Nishizawa M. Inubushi F. Ozawa K. Aki H. Okada 2007 Physiological FDG uptake in the ovaries after hysterectomy Ann Nucl Med 21 345 348
7. C.H. Kao 2003 FDG uptake in a huge uterine myoma Clin Nucl Med 28 249
8. I. Ak S. Ozalp O.T. Yalcin E. Zor E. Vardareli 2004 Uptake of 2-[18F]fluoro-2-deoxy-d-glucose in uterine leiomyoma: imaging of four patients by coincidence positron emission tomography Nucl Med Commun 25 941 945
9. J.C. Chura A.M. Truskinovsky P.L. Judson L. Johnson M.A. Geller L.S. Downs Jr 2007 Positron emission tomography and leiomyomas: clinicopathologic analysis of 3 cases of PET scanpositive leiomyomas and literature review Gynecol Oncol 104 247 252
10. M. Shida M. Murakami H. Tsukada Y. Ishiguro K. Kikuchi E. Yamashita 2007 F-18 fluorodeoxyglucose uptake in leiomyomatous uterus Int J Gynecol Cancer 17 285 290
11. M. Watanabe K. Shimizu T. Omura N. Sato M. Takahashi T. Kosugi 2004 A high-throughput whole-body PET scanner using flat panel PS-PMTs IEEE Trans Nucl Sci 51 796 800
12. G.J. Förster C. Laumann O. Nickel P. Kann O. Pieker P. Bartenstein 2003 SPET/CT image co-registration in the abdomen with a simple and cost-effective tool Eur J Nucl Med Mol Imaging 30 32 39
13. Y. Nakamoto S. Sakamoto T. Okada K. Matsumoto E. Minota H. Kawashima 2005 Accuracy of image fusion using a fixation device for whole-body cancer imaging AJR Am J Roentgenol 184 1960 1966
14. E. Tanaka H. Kudo 2003 Subset-dependent relaxation in block-iterative algorithms for image reconstruction in emission tomography Phys Med Biol 48 1405 1422
15. B.J. Vollenhoven A.S. Lawrence D.L. Healy 1990 Uterine fibroids: a clinical review Br J Obstet Gynecol 97 285 298
16. S.E. Brooks M. Zhan T. Cote C.R. Baquet 2004 Surveillance, epidemiology and end results analysis of 2677 cases of uterine sarcoma 1989-1999 Gynecol Oncol 93 204 208
17. E. Murase E.S. Siegelman E.K. Outwater L.A. Perez-Jaffe R.W. Tureck 1999 Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis, and treatment Radiographics 19 1179 1197
18. 18F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging Gynecol Oncol 80 372 377
19. S. Nishizawa M. Inubushi H. Okada F. Ozawa S. Kojima S. Teramukai 2006 Cancer screening trial to evaluate the efficacy of FDG PET in healthy subjects: 2-year results of the Hamamatsu Medical Imaging Center study (abstract) J CLin Oncol 24 Suppl18 1025
20. T. Maruo N. Ohara J.W. Wang H. Matuo 2004 Sex steroidal regulation of uterine leiomyoma growth and apoptosis Human Reprod Update 10 207 220
21. T. Maruo H. Matsuo T. Samoto Y. Shimomura O. Kurachi Z. Gao 2000 Effects of progesterone on uterine leiomyoma growth and apoptosis Steroid 65 585 592
22. S.V. Pavlovich N.I. Volkov V.A. Burlev 2003 Proliferative activity and level of steroid hormone receptors in the myometrium and myoma nodes in different phases of menstrual cycle Bull Exp Biol Med 136 396 398
23. K. Kawaguchi S. Fujii I. Konishi Y. Nanbu T. Mori 1989 Mitotic activity in uterine leiomyoma during the menstrual cycle Am J Obstet Gynecol 160 637 641
24. 18F-FDG uptake: is there a contribution of the endothelium? J Nucl Med 45 461 462
25. 18F-FDG uptake in human breast cancer measured by positron emission tomography J Clin Oncol 20 379 387
26. K. Ito T. Kato T. Ohta M. Tadikoro T. Yamada M. Ikeda 1996 Fluorine-18 fluoro-2-deoxyglucose positron emission tomography in recurrent rectal cancer: relation to tumour size and cellularity Eur J Nucl Med 23 1372 1377
27. K.L. Berger S.A. Nicholson F. Dehdashti B.A. Siegel 2000 FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features Am J Roentgenol 174 1005 1008
28. B. Lippitz U. Cremerius L. Mayfrank H. Bertalanffy R. Raoofi J. Weis 1996 PET-study of intracranial meningiomas: correlation with histopathology, cellularity and proliferation rate Acta Neurochir Suppl 65 108 111
29. T. Higashi N. Tamaki T. Torizuka Y. Nakamoto H. Sakahara T. Kimura 1998 FDG uptake, GLUT-1 glucose transporter and cellularity in human pancreatic tumors J Nucl Med 39 1727 1735